UM

Browse/Search Results:  1-2 of 2 Help

Selected(0)Clear Items/Page:    Sort:
Nanoparticles for co-delivery of paclitaxel and curcumin to overcome chemoresistance against breast cancer Journal article
Lin, Xiangping, Wang, Qun, Du, Shuang, Guan, Yucheng, Qiu, Jinmei, Chen, Xiaojia, Yuan, Dongsheng, Chen, Tongkai. Nanoparticles for co-delivery of paclitaxel and curcumin to overcome chemoresistance against breast cancer[J]. Journal of Drug Delivery Science and Technology, 2023, 79.
Authors:  Lin, Xiangping;  Wang, Qun;  Du, Shuang;  Guan, Yucheng;  Qiu, Jinmei; et al.
Favorite | TC[WOS]:22 TC[Scopus]:22  IF:4.5/4.7 | Submit date:2023/02/01
Breast Cancer  Paclitaxel  Curcumin  Co-delivery  Polymeric Nanoparticles  Nf-κb Signaling Pathway  
A tumor-targeted delivery of oral isoliquiritigenin through encapsulated zein phosphatidylcholine hybrid nanoparticles prevents triple-negative breast cancer Journal article
Wang, Yan, Zhang, Chen, Xiao, Meng, Ganesan, Kumar, Gao, Fei, Liu, Qingqing, Ye, Zhen, Sui, Yue, Zhang, Feng, Wei, Kunhua, Wu, Yaobin, Wu, Jianmin, Du, Bing, Xu, Cong, Li, Yan, Li, Peng, Zhang, Jinming, Chen, Jianping. A tumor-targeted delivery of oral isoliquiritigenin through encapsulated zein phosphatidylcholine hybrid nanoparticles prevents triple-negative breast cancer[J]. Journal of Drug Delivery Science and Technology, 2023, 79.
Authors:  Wang, Yan;  Zhang, Chen;  Xiao, Meng;  Ganesan, Kumar;  Gao, Fei; et al.
Favorite | TC[WOS]:13 TC[Scopus]:12  IF:4.5/4.7 | Submit date:2023/02/01
Isoliquiritigenin  Zein-phosphatidylcholine Hybrid Nanoparticles  Bioavailability  Triple-negative Breast Cancer  Safe Therapeutic Strategy